Featured Research

from universities, journals, and other organizations

Engineered Proteins Restore Light Sensitivity To Animals

Date:
October 21, 2009
Source:
Society for Neuroscience
Summary:
Engineered, light-sensitive molecules introduced into a blind rodent's eye resulted in vision, according to results from an interdisciplinary collaboration between numerous labs. The results could lead to treatments for people with inherited, blinding eye diseases such as retinitis pigmentosa, which affects one in every 3,000 individuals.

Engineered, light-sensitive molecules introduced into a blind rodent's eye resulted in vision, according to results from an interdisciplinary collaboration between numerous labs. The results could lead to treatments for people with inherited, blinding eye diseases such as retinitis pigmentosa, which affects one in every 3,000 individuals.

The findings were presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

In past studies, researchers made a blind animal's visual cells respond to light by introducing a light-sensitive algae protein into the eye. This new study manipulates existing proteins that our brains normally use to transmit information between neurons, and makes them light sensitive.

The researchers focused on several light-sensitive proteins, each with its own unique properties that could be fine- tuned to meet researchers' specific needs. One such engineered protein, LiGluR (Light Activated Glutamate Receptor), can turn neuronal activity on and off upon illumination with specific wavelengths of light. There are many glutamate receptors in the human brain, but they are not normally light sensitive.

"Our approach was to build on these initial studies, to 're-engineer nature,' by solving a deficit with engineered light-sensitive proteins," said Natalia Caporale, PhD, at the University of California Berkeley, the study's first author. "This approach could prove to be a viable therapeutic option for people who have lost significant vision and are in the late stages of retinal degeneration," she said.

Compared with naturally occurring photosensitive proteins, LiGluR can initiate larger and longer-lasting responses in neurons, making it a promising candidate for treatments intended to restore vision.

Research was supported by the Nanomedicine Development Center for the Optical Control of Biological Function and the Foundation Fighting Blindness.


Story Source:

The above story is based on materials provided by Society for Neuroscience. Note: Materials may be edited for content and length.


Cite This Page:

Society for Neuroscience. "Engineered Proteins Restore Light Sensitivity To Animals." ScienceDaily. ScienceDaily, 21 October 2009. <www.sciencedaily.com/releases/2009/10/091021014732.htm>.
Society for Neuroscience. (2009, October 21). Engineered Proteins Restore Light Sensitivity To Animals. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/10/091021014732.htm
Society for Neuroscience. "Engineered Proteins Restore Light Sensitivity To Animals." ScienceDaily. www.sciencedaily.com/releases/2009/10/091021014732.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins